This paper is only available as a PDF. To read, Please Download here.
Abstract
Purpose
A third of familial epithelial ovarian cancer (EOC) is explained by BRCA1/2 pathogenic variants (PVs). Polygenic risk scores (PRSs) for BRCA1/2-heterozygotes associated with EOC have been created but impact of combination with clinical and hormonal risk factors is unclear.
Methods
We genotyped 300 cases and 355 controls and constructed modified PRSs based on those validated by Barnes et al. Model discrimination and EOC risk was assessed by area under the curve (AUC) values and difference between lowest and highest quintile odds ratios (ORs). We investigated model optimisation using logistic regression to combine models with clinical and hormonal data.
Results
Unadjusted AUC values were 0.526-0.551 with 2.2-2.3-fold increase in OR between lowest and highest quintiles (BRCA1-heterozygotes) and 0.574-0.585 AUC values with a 6.3-7.7-fold increase (BRCA2-heterozygotes). The optimised model (parity, age at menarche, menopause and first full-term pregnancy) estimated AUC values 0.872-0.876 and 21-23-fold increase in OR (BRCA1-heterozygotes) and AUC values of 0.857-0.867 and 40-41-fold increase (BRCA2-heterozygotes).
Conclusions
The combination of PRS with age, family history, and hormonal factors significantly improved the EOC risk discrimination ability. However, the contribution of the PRS was small. Larger prospective studies are needed to assess if combined-PRS models could provide information to inform risk-reducing decisions.
Article info
Publication history
Accepted:
May 16,
2023
Received in revised form:
May 16,
2023
Received:
December 21,
2022
Publication stage
In Press Accepted ManuscriptFootnotes
Co-authors’ email addresses
Identification
Copyright
© 2023 Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy
